ResMed Inc. (RMD) News

ResMed Inc. (RMD): $158.82

1.09 (+0.69%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Filter RMD News Items

RMD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

RMD News Highlights

  • For RMD, its 30 day story count is now at 17.
  • Over the past 18 days, RMD's stories per day has been in a clear downtrend, falling by about 0.46 per 3 days.
  • ASX, BAND and GLP are the most mentioned tickers in articles about RMD.

Latest RMD News From Around the Web

Below are the latest news stories about RESMED INC that investors may wish to consider to help them evaluate RMD as an investment opportunity.

Resmed overhauls C-suite, creating 3 posts and parting ways with 2 execs

The company recently laid off 5% of its staff and stopped certain projects to lower operating costs.

Yahoo | November 13, 2023

Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why

Key Insights ResMed's Annual General Meeting to take place on 16th of November Salary of US$1.13m is part of CEO Mick...

Yahoo | November 10, 2023

ResMed Adopts New Operating Model to Accelerate Long-term Growth

Justin Leong appointed Chief Product Officer, effective immediately.Katrin Pucknat appointed Chief Marketing Officer, effective immediately.Mike Fliss appointed Chief Revenue Officer, effective immediately.Rob Douglas, President and Chief Operating Officer, to retire January 1, 2024. SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to accelerate long-term growth. The new operating model introduces dedicated leadership in Product, Rev

Yahoo | November 9, 2023

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Yahoo | November 7, 2023

ResMed Inc's Dividend Analysis

ResMed Inc(NYSE:RMD) recently announced a dividend of $0.48 per share, payable on 2023-12-14, with the ex-dividend date set for 2023-11-08. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into ResMed Inc's dividend performance and assess its sustainability.

Yahoo | November 7, 2023

2 Monster Stocks to Buy Without Any Hesitation

First, consumer health juggernaut Kenvue (NYSE: KVUE) produces and markets seven No. 1 global brands. Meanwhile, ResMed (NYSE: RMD), a leader in continuous positive airway pressure (CPAP) machines, has delivered enormous total returns of over 24,000% since its initial public offering (IPO) in 1995. Home to seven No. 1 global brands -- Tylenol, Nicorette, Zyrtec, Neutrogena, Listerine, Johnson's, and Band-Aid -- Kenvue operates in 165 countries.

Yahoo | November 7, 2023

Be Sure To Check Out ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend

ResMed Inc. ( NYSE:RMD ) stock is about to trade ex-dividend in 4 days. Typically, the ex-dividend date is one business...

Yahoo | November 3, 2023

Health Care Roundup: Market Talk

Find insight on Hypera, Krispy Kreme, Inspecs and more in the latest Market Talks covering the Health Care sector.

Yahoo | October 30, 2023

Resmed cuts 5% of staff amid profitability push

The company has stopped some projects that were not working well as it seeks to cut operating costs, CEO Mick Farrell told investors.

Yahoo | October 30, 2023

ResMed Inc. (NYSE:RMD) Q1 2024 Earnings Call Transcript

ResMed Inc. (NYSE:RMD) Q1 2024 Earnings Call Transcript October 26, 2023 ResMed Inc. beats earnings expectations. Reported EPS is $1.64, expectations were $1.62. Operator: Hello, and welcome to the ResMed First Quarter Fiscal Year 2024 Earnings Conference Call and Webcast [Operator Instructions]. As a reminder, this conference is being recorded. It’s now my pleasure to […]

Yahoo | October 27, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!